Davis R M Inc. grew its stake in shares of Henry Schein, Inc. (NASDAQ:HSIC) by 104.8% in the 3rd quarter, according to its most recent disclosure with the SEC. The institutional investor owned 484,322 shares of the company’s stock after acquiring an additional 247,842 shares during the period. Henry Schein comprises approximately 1.6% of Davis R M Inc.’s investment portfolio, making the stock its 17th biggest holding. Davis R M Inc. owned approximately 0.31% of Henry Schein worth $39,710,000 at the end of the most recent reporting period.
Other large investors have also modified their holdings of the company. YorkBridge Wealth Partners LLC increased its position in shares of Henry Schein by 5.2% during the second quarter. YorkBridge Wealth Partners LLC now owns 570 shares of the company’s stock worth $104,000 after purchasing an additional 28 shares in the last quarter. Sun Life Financial INC grew its holdings in shares of Henry Schein by 8,185.7% during the second quarter. Sun Life Financial INC now owns 580 shares of the company’s stock valued at $106,000 after buying an additional 573 shares during the last quarter. Lee Financial Co purchased a new stake in shares of Henry Schein during the second quarter valued at $161,000. Acrospire Investment Management LLC grew its holdings in shares of Henry Schein by 150.0% during the second quarter. Acrospire Investment Management LLC now owns 1,000 shares of the company’s stock valued at $183,000 after buying an additional 600 shares during the last quarter. Finally, HM Payson & Co. purchased a new stake in shares of Henry Schein during the second quarter valued at $204,000. 48.16% of the stock is owned by institutional investors.
In other news, SVP Paul Rose sold 2,126 shares of the stock in a transaction that occurred on Wednesday, September 6th. The shares were sold at an average price of $172.51, for a total value of $366,756.26. Following the completion of the sale, the senior vice president now owns 17,841 shares of the company’s stock, valued at approximately $3,077,750.91. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Corporate insiders own 1.19% of the company’s stock.
HSIC has been the topic of a number of research analyst reports. Robert W. Baird set a $95.00 price objective on shares of Henry Schein and gave the company a “buy” rating in a report on Thursday, October 19th. Northcoast Research raised shares of Henry Schein from a “neutral” rating to a “buy” rating and set a $109.00 price target on the stock in a report on Monday, August 7th. UBS AG reaffirmed a “buy” rating on shares of Henry Schein in a report on Friday, September 15th. Craig Hallum raised shares of Henry Schein from a “hold” rating to a “buy” rating in a report on Tuesday. Finally, TheStreet lowered shares of Henry Schein from a “b” rating to a “c+” rating in a report on Monday, November 6th. One research analyst has rated the stock with a sell rating, nine have issued a hold rating and seven have given a buy rating to the stock. The stock presently has a consensus rating of “Hold” and a consensus target price of $89.88.
TRADEMARK VIOLATION WARNING: “Henry Schein, Inc. (HSIC) Shares Bought by Davis R M Inc.” was reported by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are viewing this article on another publication, it was illegally stolen and reposted in violation of US and international copyright and trademark law. The legal version of this article can be read at https://www.dispatchtribunal.com/2017/11/11/davis-r-m-inc-has-39-71-million-position-in-henry-schein-inc-hsic.html.
Henry Schein, Inc. (NASDAQ HSIC) traded down $2.61 during mid-day trading on Friday, reaching $67.05. 5,071,400 shares of the company’s stock were exchanged, compared to its average volume of 1,106,182. The firm has a market cap of $10,933.44, a P/E ratio of 19.54, a price-to-earnings-growth ratio of 1.96 and a beta of 1.03. The company has a debt-to-equity ratio of 0.30, a quick ratio of 0.85 and a current ratio of 1.55. Henry Schein, Inc. has a 12 month low of $67.02 and a 12 month high of $93.50.
Henry Schein (NASDAQ:HSIC) last posted its quarterly earnings results on Monday, November 6th. The company reported $0.87 earnings per share for the quarter, missing the consensus estimate of $0.90 by ($0.03). Henry Schein had a net margin of 4.52% and a return on equity of 19.71%. The firm had revenue of $3.16 billion during the quarter, compared to analysts’ expectations of $3.05 billion. During the same period last year, the company earned $0.84 EPS. The business’s quarterly revenue was up 10.3% on a year-over-year basis. analysts anticipate that Henry Schein, Inc. will post 3.6 earnings per share for the current year.
Henry Schein declared that its Board of Directors has approved a stock buyback plan on Monday, September 18th that allows the company to repurchase $400.00 million in shares. This repurchase authorization allows the company to reacquire up to 6.3% of its shares through open market purchases. Shares repurchase plans are generally a sign that the company’s leadership believes its stock is undervalued.
Henry Schein Company Profile
Henry Schein, Inc is a provider of healthcare products and services primarily to office-based dental, animal health and medical practitioners. The Company operates through two segments: healthcare distribution, and technology and value-added services. The healthcare distribution segment distributes consumable products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products and vitamins.
Receive News & Ratings for Henry Schein Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein Inc. and related companies with MarketBeat.com's FREE daily email newsletter.